Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Narrative (Details)

v3.20.1
Commitments and Contingencies - Narrative (Details)
3 Months Ended
Mar. 16, 2020
USD ($)
agreement
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Commitments and Contingencies      
Lease cost   $ 29,000 $ 8,000
Short-term lease cost   4,000 14,000
Variable lease cost   7,000 5,000
Sublease income   10,000  
Research and development   3,206,000 2,932,000
MD Anderson | License      
Commitments and Contingencies      
Cost of services   61,000 60,000
Houston Pharmaceuticals, Inc.      
Commitments and Contingencies      
Other commitment, number of agreements | agreement 2    
Houston Pharmaceuticals, Inc. | License      
Commitments and Contingencies      
Cost of services   207,500 75,000
MD Anderson      
Commitments and Contingencies      
Research and development   $ 179,000 $ 95,000
Consulting Agreement on Licensed Molecules | Houston Pharmaceuticals, Inc.      
Commitments and Contingencies      
Other commitment, term 2 years    
Other commitment $ 43,500    
Agreement Providing Access to Laboratory Equipment | Houston Pharmaceuticals, Inc.      
Commitments and Contingencies      
Other commitment $ 15,000    
Other commitments, cancellation period 60 days